Source: FinanzNachrichten

Biogen: Biogen Inc.: Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

CAMBRIDGE, Mass., Oct. 24, 2024Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer's Disease (CTAD) annual conference, taking place October...

Read full article »
Biogen's Competitors | Biogen's News | Biogen's Financials
Stay up-to-date with the latest news on Biogen
Annual Revenue
$5.0-10B
Employees
5.0-10K
Christopher A. Viehbacher's photo - President & CEO of Biogen

President & CEO

Christopher A. Viehbacher

CEO Approval Rating

48/100

Read more
Stay up-to-date with the latest news on Biogen